Aurinia Pharmaceuticals Inc. (AUPH) market cap

Market cap today
$2.06B

Aurinia Pharmaceuticals Inc. (AUPH) has a market cap of $2.06B. At the end of fiscal 2025 (December 31, 2025) its market cap was $2.21B. That is 68.5% higher than the $1.31B of fiscal 2024. Today's figure is 6.7% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:37 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$2.06B
Market cap, fiscal 2025
$2.21B
Change on fiscal 2024
+68.5%
Growth, 5 years
+6.2% a year
Highest on record
$2.96Bfiscal 2021
Lowest on record
$613.07Mfiscal 2022
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Aurinia Pharmaceuticals Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 6.2% a year. Across the 6 fiscal year-ends on record (2020–2025), the highest was $2.96B in fiscal 2021 and the lowest $613.07M in fiscal 2022.

History · 6 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Aurinia Pharmaceuticals Inc. market cap, year by year

Aurinia Pharmaceuticals Inc. (AUPH) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$2.06B—$15.40—
2025$2.21B 68.5% up$15.95138.70M
2024$1.31B 2.0% up$8.98146.19M
2023$1.29B 110.0% up$8.99143.24M
2022$613.07M 79.3% down$4.32141.92M
2021$2.96B 80.6% up$22.87129.37M
2020$1.64B—$13.83118.47M
2019——$20.26—
2018——$6.82—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on AUPH

Aurinia Pharmaceuticals Inc., figure by figure

Aurinia Pharmaceuticals Inc. (AUPH) overview: price, valuation and scorecard

Aurinia Pharmaceuticals Inc. market cap: questions and answers

What is Aurinia Pharmaceuticals Inc.'s market cap?

Aurinia Pharmaceuticals Inc. (AUPH) has a market cap of $2.06B. At the end of fiscal 2025 (December 31, 2025) its market cap was $2.21B. That is 68.5% higher than the $1.31B of fiscal 2024.

What is the growth rate of Aurinia Pharmaceuticals Inc.'s market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 6.2% a year.

What are the highest and lowest market cap figures on record for Aurinia Pharmaceuticals Inc.?

Across the 6 fiscal year-ends on record (2020–2025), the highest was $2.96B in fiscal 2021 and the lowest $613.07M in fiscal 2022.

How is Aurinia Pharmaceuticals Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Aurinia Pharmaceuticals Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Aurinia Pharmaceuticals Inc. (AUPH) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/AUPH/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.